Showing results (11-20 of 68) with videos related to
Sort By:
Pageof 7
Journal of the American Chemical Society|December 15, 2005
Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agentsArie Zask, Joshua Kaplan, Sylvia Musto, et al.Bioorganic & Medicinal Chemistry Letters|March 13, 2010
Triazines incorporating (R)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3KalphaDavid J Richard, Jeroen C Verheijen, Ker Yu, et al.Organic Letters|November 17, 2006
Spin-trapping of the p-benzyne intermediates from ten-membered enediyne calicheamicin gamma1IToyonobu Usuki, Koji Nakanishi, George A EllestadCancer Biology & Therapy|December 7, 2007
Response and determinants of cancer cell susceptibility to PI3K inhibitors: combined targeting of PI3K and Mek1 as an effective anticancer strategyKer Yu, Lourdes Toral-Barza, Celine Shi, et al.Bioorganic & Medicinal Chemistry Letters|November 10, 2009
Discovery of 2-arylthieno[3,2-d]pyrimidines containing 8-oxa-3-azabi-cyclo[3.2.1]octane in the 4-position as potent inhibitors of mTOR with selectivity over PI3KJeroen C Verheijen, Ker Yu, Lourdes Toral-Barza, et al.Organic Letters|May 21, 2004
A re-examination of the circular dichroism of the calicheamicin enediyne/dienone chromophoric interactionWeidong Ding, Keith Pitts, George A Ellestad, et al.Journal of Pharmaceutical and Biomedical Analysis|May 28, 2017
Circular dichroism analysis of the calicheamicin-DNA interaction revisitedGloria Proni, Kristi Tami, Nina Berova, et al.Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Absolute configurations of tubulin inhibitors taltobulin (HTI-286) and HTI-042 characterized by X-ray diffraction analysis and NMR studiesChuansheng Niu, Douglas M Ho, Robert Thomas Williamson, et al.Chemical Communications (Cambridge, England)|January 21, 2010
Calicheamicin γ1(I) and phenyl tert-butyl nitrone (PBN): observation of a kinetic isotope effect by an ESR studyToyonobu Usuki, Mari Kawai, Koji Nakanishi, et al.Bioorganic & Medicinal Chemistry Letters|March 13, 2010
2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines as highly potent and selective ATP competitive mTOR inhibitors: optimization of human microsomal stabilityJeroen C Verheijen, David J Richard, Kevin Curran, et al.Pageof 7